Movatterモバイル変換


[0]ホーム

URL:


MY115721A - Benzothiophene compounds, intermediates, compositionsm, and methods - Google Patents

Benzothiophene compounds, intermediates, compositionsm, and methods

Info

Publication number
MY115721A
MY115721AMYPI96000722AMYPI9600722AMY115721AMY 115721 AMY115721 AMY 115721AMY PI96000722 AMYPI96000722 AMY PI96000722AMY PI9600722 AMYPI9600722 AMY PI9600722AMY 115721 AMY115721 AMY 115721A
Authority
MY
Malaysia
Prior art keywords
alkyl
compositionsm
intermediates
methods
compounds
Prior art date
Application number
MYPI96000722A
Inventor
Alan David Palkowitz
Kenneth Jeff Thrasher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/396,401external-prioritypatent/US5510357A/en
Priority claimed from US08/552,679external-prioritypatent/US5856339A/en
Priority claimed from US08/554,223external-prioritypatent/US5856340A/en
Priority claimed from US08/552,890external-prioritypatent/US5919800A/en
Priority claimed from US08/552,564external-prioritypatent/US5998441A/en
Priority claimed from US08/552,565external-prioritypatent/US5977093A/en
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of MY115721ApublicationCriticalpatent/MY115721A/en

Links

Classifications

Landscapes

Abstract

THE PRESENT INVENTION PROVIDES PHARMACEUTICALLY ACTIVE COMPOUNDS OF FORMULA I WHEREIN RL IS -H, -OH, -O(CL-C4 ALKYL), -OCOC6H5, -OCO(CL-C6 ALKYL), OR -OSO2(C2-C6 ALKYL); R2 IS -H, -OH, -O(CL-C4 ALKYL), -OCOC6H5, -OCO(CL-C6 ALKYL), -OSO2(C2-C6 ALKYL), OR HALO; R3 IS 1-PIPERIDINYL, 1-PYR~OLIDINYL, METHYL-1- PYRROLIDINYL, DIMETHYL-1-PYRROLIDINYL, 4-MORPHOLINO, DIMETHYLAMINO, DIETHYLAMINO, DIISOPROPYLAMINO, OR 1- HEX AM ETHYLENE IMINO; N IS 2 OR 3; AND Z IS -O- OR -S-; OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.FURTHER PROVIDED ARE PHARMACEUTICAL COMPOSITIONS OF COMPOUNDS OF FORMULA I.
MYPI96000722A1995-02-281996-02-28Benzothiophene compounds, intermediates, compositionsm, and methodsMY115721A (en)

Applications Claiming Priority (8)

Application NumberPriority DateFiling DateTitle
US08/396,401US5510357A (en)1995-02-281995-02-28Benzothiophene compounds as anti-estrogenic agents
US55276095A1995-11-031995-11-03
US08/552,636US5723474A (en)1995-02-281995-11-03Benzothiophene compounds, intermediates, compositions, and methods
US08/552,679US5856339A (en)1995-02-281995-11-03Benzothiophene compounds, intermediates, compositions, and methods
US08/554,223US5856340A (en)1995-02-281995-11-03Method of treating estrogen dependent cancers
US08/552,890US5919800A (en)1995-02-281995-11-03Benzothiophene compounds, intermediates, compositions, and methods
US08/552,564US5998441A (en)1995-02-281995-11-03Benzothiophene compounds, intermediates, compositions, and methods
US08/552,565US5977093A (en)1995-02-281995-11-03Benzothiophene compounds, intermediates, compositions, and methods

Publications (1)

Publication NumberPublication Date
MY115721Atrue MY115721A (en)2003-08-30

Family

ID=27569747

Family Applications (1)

Application NumberTitlePriority DateFiling Date
MYPI96000722AMY115721A (en)1995-02-281996-02-28Benzothiophene compounds, intermediates, compositionsm, and methods

Country Status (4)

CountryLink
KR (1)KR100446895B1 (en)
MY (1)MY115721A (en)
NZ (1)NZ286079A (en)
RS (1)RS49886B (en)

Also Published As

Publication numberPublication date
KR100446895B1 (en)2006-04-10
NZ286079A (en)1997-12-19
KR960031454A (en)1996-09-17
YU11896A (en)1998-12-23
RS49886B (en)2008-08-07

Similar Documents

PublicationPublication DateTitle
MX9600743A (en)Compounds, intermediates, compositions, and methods.
GEP20084496B (en)Benzothiophene compound, intermediate, composition, and method
YU61595A (en)New naphthyl compounds, intermediates, processes, compositions and methods for the preparation thereof
AR003930A1 (en) PROCEDURE FOR PREPARING COMPOUNDS OF 2-PHENYL-3-PHENOXY OR PHENYLTIO-BENZOTIOFEN AND PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS OF EXCLUSIVE APPLICATION IN SUCH PROCEDURE AND METHOD FOR PREPARING INTERMEDIATE COMPOUNDS
TW200420542A (en)A compound having TGF β inhibition activity and a medicinal composition containing the same
NZ326132A (en)Retroviral protease inhibiting compounds
AU6724796A (en)Non-steroidal sulfatase inhibitor compounds and their method of use
TW427887B (en)Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections
MX9605156A (en)Peptidylaldehyde derivative and use thereof.
AU7517400A (en)N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
GB9211172D0 (en)Compounds
CA2149496A1 (en)11,21-bisphenyl-19-norpregnane derivatives
MX9800718A (en)2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives.
NZ308518A (en)Antibacterial cephalosporins
MX9800800A (en)Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods.
TW372969B (en)Pharmaceutical composition for minimizing bone loss
MY115721A (en)Benzothiophene compounds, intermediates, compositionsm, and methods
GR3032492T3 (en)Interleukin-1 inhibitor
CA2170479A1 (en)Benzothiophene compounds, intermediates, compositions, and methods
YU6996A (en) USE OF BENZOTHOPHENE TO OBTAIN MEDICINE
PT832881E (en) BENZOFLUORENO COMPOUNDS INTERMEDIARY COMPOSITIONS AND METHODS
MY113757A (en)Methods of inhibiting endometrial cancer
GB2333293B (en)Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide used as anti cancer compounds
TW349096B (en)Benzothiophene compounds, intermediates, compositions, and methods

[8]ページ先頭

©2009-2025 Movatter.jp